A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma

1. Bauman, J.E.
2. Arias-Pulido, H.
3. Lee, S.-J.
4. Fekrazad, M.H.
5. Ozawa, H.
6. Fertig, E.
7. Howard, J.
8. Bishop, J.
9. Wang, H.
10. Olson, G.T.
11. Spafford, M.J.
12. Jones, D.V.
13. Chung, C.H.